Friday, July 16, 2021 2:00:54 PM
None of the optimistic prognostication and speculation about this company and its disastrous Phase 3 trial, no matter how scientifically based or intelligent-sounding, has ever been right.
Common sense says this is a failed trial and the company has been hiding it for six years. Common sense says you don't announce TLD three times in 2020 and even put in writing that you plan to release it in September 2020, and then fail to produce with no explanation and no new timeline. Common sense says something is seriously wrong when you declare data lock in October 2020 but by mid-July 2021 you haven't released TLD and have no update for shareholders or estimate of when TLD might be expected. Common sense says you don't conduct a trial for 15 years and then right before locking the data surreptitiously change the endpoints (again without telling shareholders) and change the comparisons to historical data instead of the trial's own data - unless, that is, you know the data is not good. Common sense says no one anywhere, anytime, ever, has sat on good news. People do not sit on good news for months and months and months. Common sense says that when you have bad news you sit on it while you frantically search for a way to make it sound better than it is.
That's what common sense actually says.
Yeah, that pretty well captures it. That's what it has come down to: Fortune cookies, unicorns, fantasies and fairies, wishes, hopes and dreams.
Before going further with this deep analysis I would posit two basic questions: 1) Why do the people running NWBO lie to their shareholders?, and 2) Why are they refusing to release the data?
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM